Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Conditions:   Stage I Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8;   Stage II Renal Cell Cancer AJCC v8 Intervention:   Procedure: Interstitial Radiation Therapy Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2020 Category: Research Source Type: clinical trials

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Conditions:   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer Intervention:   Procedure: Interstitial Radiation Therapy Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2020 Category: Research Source Type: clinical trials

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Conditions:   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer Intervention:   Procedure: Interstitial Radiation Therapy Sponsor:   Jonsson Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2020 Category: Research Source Type: clinical trials

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
Conditions:   Prostate Cancer;   Prostate Adenocarcinoma Interventions:   Radiation: External Beam Radiation;   Radiation: HDR Brachytherapy;   Drug: Androgen Deprivation Therapy Sponsor:   University of Virginia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
Conditions:   Prostate Adenocarcinoma;   Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8 Interventions:   Radiation: High-Dose Rate Brachytherapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Stereotactic Body Rad...
Source: ClinicalTrials.gov - May 25, 2020 Category: Research Source Type: clinical trials

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
Conditions:   Metastatic Malignant Female Reproductive System Neoplasm;   Platinum-Resistant Malignant Female Reproductive System Neoplasm;   Recurrent Malignant Female Reproductive System Neoplasm;   Refractory Malignant Female Reproductive System Neoplasm Interventions:   Biological: Durvalumab;   Radiation: Internal Radiation Therapy;   Biological: Tremelimumab Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2020 Category: Research Source Type: clinical trials